Fournier’s Gangrene Caused By SGLT2 Inhibitors Lawyers
The FDA recently announced a warning of occurrences of a type of gangrene called Fournier’s Gangrene that’s been affecting patients taking certain types of type 2 diabetes medications. The FDA warned that while rare, this type of gangrene can cause serious infections, including (in this case) necrotizing fasciitis of the perineum.
What Are SGLT2 Inhibitors?
SGLT2 stands for “sodium-glucose cotransporter-2” and they are a pharmaceutical approved by the FDA to, with the addition of diet and exercise, can help lower blood sugar in patients with type 3 diabetes.
These drugs were first approved in 2013, and they help lower blood sugars by increasing the amount of sugar removed from the blood through the kidneys, allowing it to pass out of the body through urine. This type of drug is strictly for patients with type 2 diabetes, and it was not been approved to treat any other type of diabetes.
What Types of SLGLT2 Inhibitors Are Possibly Causing Fourniers Gangrene?
The SGLT2 Inhibitor class of medicines includes the following:
Additionally, the brand names associated with this type of drug include:
- Invokamet XR
- Xigduo XR
If you or a loved one has been prescribed these types of medications, don’t hesitate to call us at 1-800-590-4116 to learn how our team can get you compensation for your injuries, and recovery.
Why Is This Medication Causing Fourniers Gangrene? What Are The Symptoms?
Fournier’s and other types of gangrene are caused by a bacterial infection that often enters the body through a cut or break in the skin, where the bacteria quickly multiplies and destroys the tissue they are infecting. Gangrene is also characterized by a lack of blood flow to the affected region.
Early symptoms of Fournier’s gangrene are the warning signs of a serious infection, and if you or a loved one is showing these symptoms don’t hesitate to bring these to the attention of a doctor.
These symptoms can include:
- Skin discoloration — ranging from pale to blue, purple, black, bronze or red, depending on the type of gangrene you have
- Swelling or the formation of blisters filled with fluid on the skin
- A clear line between healthy and damaged skin
- Sudden, severe pain followed by a feeling of numbness
- A foul-smelling discharge leaking from a sore
- Thin, shiny skin, or skin without hair
- Skin that feels cool or cold to the touch
These symptoms most commonly presented themselves in men between the ages of 50 to 79 years old, though it’s worth noting that when caused by SLGT2 Inhibitors, there was an alarming rise in cases involved females, some as young as 33 years of age.
Over 12 cases of Fourniers were identified by the FDA as being caused by SLGT2 Inhibitors between March 2013 and May 2018. These victims contained seven men, and five women.
How Should I Determine Whether I Have A Case?
If you or a loved one experienced gangrene, or even an amputation after being prescribed an SLGT2 Inhibitor your best action is to consult with an expert law firm like McEldrew Young Purtell Merritt as soon as possible.
Doctors and hospitals may not have been aware of the damaging effects of these pharmaceuticals when they were first approved for the market, and so you may not even know that your gangrene had been caused by an SLGT2 Inhibitor in the first place. Don’t hesitate to call us – we can help you figure out whether your injury deserves compensation.
With 30 years of experience in cases of dangerous pharmaceuticals and drugs, McEldrew Young Purtell Merritt is well suited to evaluate the situation and help determine if the injury suffered involved acts of medical negligence or professional malpractice. All of our cases are handled on a contingency basis.